Evidence map›Paper›PMID 34268625›Full record

ArticleJournal of gastroenterology2021

Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type.

Hiroya Ueyama, Takashi Yao, Yoichi Akazawa, Takuo Hayashi, Koichi Kurahara, Yumi Oshiro, Masayoshi Yamada, Ichiro Oda, Shin Fujioka, Chiaki Kusumoto and 31 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Clinicopathological characterization of extremely low-grade fundic gland tumors: a study of 11 of a variant of oxyntic gland adenomas.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  5. Article
  6. Review
  7. Gastric Adenomas and Mimickers: A Review.Diagnostics (Basel, Switzerland) · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Contract to kill: GNAS mutation.Molecular cancer · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 1 country.

Hiroya UeyamaDepartment of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan. psyro@juntendo.ac.jp.ORCID 0000-0002-5370-1009
Takashi YaoDepartment of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yoichi AkazawaDepartment of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.
Takuo HayashiDepartment of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.
Koichi KuraharaDepartment of Gastroenterology, Matsuyama Red Cross Hospital, Ehime, Japan.
Yumi OshiroDepartment of Pathology, Matsuyama Red Cross Hospital, Ehime, Japan.
Masayoshi YamadaEndoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Ichiro OdaEndoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Shin FujiokaDivision of Gastroenterology, Fukuoka Red Cross Hospital, Fukuoka, Japan.
Chiaki KusumotoDepartment of Gastroenterology, Nippon Kokan Fukuyama Hospital, Hiroshima, Japan.
Masayoshi FukudaDepartment of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Kunihisa UchitaDepartment of Gastroenterology, Kochi Red Cross Hospital, Kochi, Japan.
Tomohiro KadotaDepartment of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.
Yasuhiro OonoDepartment of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.
Kazuhisa OkamotoDepartment of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan.
Kazunari MurakamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan.
Yasumasa MatsuoDivision of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
Motohiko KatoDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Tadateru MaehataDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Naohisa YahagiDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Yumiko YasuharaDepartment of Diagnostic Pathology, Kyoto-Katsura Hospital, Kyoto, Japan.
Tomoyuki YadaDepartment of Gastroenterology & Hepatology, National Center for Global Health and Medicine, Kohnodai Hospital, Chiba, Japan.
Koji UraushiharaDepartment of Gastroenterology and Hepatology, Showa General Hospital, Tokyo, Japan.
Tetsumi YamaneDepartment of Diagnostic Pathology, Tottori Red Cross Hospital, Tottori, Japan.
Taiji MatsuoDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Masanori ItoDepartment of General Internal Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Yasuhiko MaruyamaDepartment of Gastroenterology, Fujieda Municipal General Hospital, Shizuoka, Japan.
Ayumi OsakoDepartment of Gastroenterology, Tottori Seikyo Hospital, Tottori, Japan.
Shoko OnoDepartment of Gastroenterology, Hokkaido University Hospital, Hokkaido, Japan.
Mototsugu KatoDepartment of Gastroenterology, National Hospital Organization Hakodate National Hospital, Hokkaido, Japan.
Kazuyoshi YagiDepartment of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan.
Takashi HashimotoDepartment of Esophageal and Gastroenterological Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Natsumi TomitaDepartment of Esophageal and Gastroenterological Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Sho TsuyamaDepartment of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.
Tsuyoshi SaitoDepartment of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.
Kohei MatsumotoDepartment of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.
Kenshi MatsumotoDepartment of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.
Sumio WatanabeDepartment of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.
Naomi UemuraDepartment of Gastroenterology & Hepatology, National Center for Global Health and Medicine, Kohnodai Hospital, Chiba, Japan.
Tsutomu ChibaDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Akihito NagaharaDepartment of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.
Juntendo University · JPKeio University · JPNational Cancer Center Hospital East · JPHiroshima University Hospital · JPMatsuyama Red Cross Hospital · JPNational Center for Global Health and Medicine · JPOita University · JPFujieda Municipal General Hospital · JPFukuyama Cardiovascular Hospital · JPHokkaido University Hospital · JPJapanese Red Cross Fukuoka Hospital · JPJapanese Red Cross Kochi Hospital · JPKyoto Katsura Hospital · JPKyoto University · JPNiigata University Medical and Dental Hospital · JPShowa General Hospital · JPSt. Marianna University School of Medicine · JPTokyo Medical and Dental University · JPTottori Prefectural Central Hospital · JPTottori University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric adenocarcinoma of fundic-gland type (GA-FG) is a rare variant of gastric neoplasia. However, the etiology, classification, and clinicopathological features of gastric epithelial neoplasm of fundic-gland mucosa lineage (GEN-FGML; generic term of GA-FG related neoplasm) are not fully elucidated. We performed a large, multicenter, retrospective study to establish a new classification and clarify the clinicopathological features of GEN-FGML.

methodsOne hundred GEN-FGML lesions in 94 patients were collected from 35 institutions between 2008 and 2019. We designed a new histopathological classification of GEN-FGML using immunohistochemical analysis and analyzed via clinicopathological, immunohistochemical, and genetic evaluation.

resultsGEN-FGML was classified into 3 major types; oxyntic gland adenoma (OGA), GA-FG, and gastric adenocarcinoma of fundic-gland mucosa type (GA-FGM). In addition, GA-FGM was classified into 3 subtypes; Type 1 (organized with exposure type), Type 2 (disorganized with exposure type), and Type 3 (disorganized with non-exposure type). OGA and GA-FG demonstrated low-grade epithelial neoplasm, and GA-FGM should be categorized as an aggressive variant of GEN-FGML that demonstrated high-grade epithelial neoplasm (Type 2 > 1, 3). The frequent presence of GNAS mutation was a characteristic genetic feature of GEN-FGML (7/34, 20.6%; OGA 1/3, 33.3%; GA-FG 3/24, 12.5%; GA-FGM 3/7, 42.9%) in mutation analysis using next-generation sequencing.

conclusionsWe have established a new histopathological classification of GEN-FGML and propose a new lineage of gastric epithelial neoplasm that harbors recurrent GNAS mutation. This classification will be useful to estimate the malignant potential of GEN-FGML and establish an appropriate standard therapeutic approach.

Indexed as

Cell LineageAgedFemaleHumansMaleMiddle AgedPain MeasurementPolypsRetrospective StudiesStomach NeoplasmsGastric adenocarcinoma of fundic-gland mucosa typeGastric adenocarcinoma of fundic-gland typeGastric epithelial neoplasm of fundic-gland mucosa lineageOxyntic gland adenoma

Identifiers

PMID34268625
PMCPMC8370942
OpenAlexW3180326644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.